Почетна › Мажорна депресивна поремећеност › Florida
Kliničke studije za Мажорна депресивна поремећеност u državi Florida
33 studija za Мажорна депресивна поремећеност traži učesnike na lokacijama u državi Florida.
Gradovi u državi Florida
- Orlando18 студија
- Miami17 студија
- Tampa17 студија
- Jacksonville12 студија
- Hollywood7 студија
- West Palm Beach6 студија
- Hialeah6 студија
- Brandon5 студија
- Palm Bay4 студија
- Miami Gardens4 студија
- Naples4 студија
- Cape Coral3 студија
- Deltona3 студија
Zvanični tekst studije (na engleskom)
A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder
- CNS Healthcare, Jacksonville
- Accel Research Sites - Maitland, Maitland
- Aqualane Clinical Research, Naples
- и још 1
Тражи се учесникФаза 3
Узраст од 18 до 85 · Оба пола · Ажурирано 13. 11. 2026. · NCT06793397A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)
- Seaport Investigator Site, Jacksonville
- Seaport Investigator Site, Lauderhill
- Seaport Investigator Site, Orlando
- и још 2
Тражи се учесникФаза 2
Узраст од 18 до 65 · Оба пола · Ажурирано 10. 11. 2026. · NCT07065240A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)
- Clinical Neuroscience Solutions, LLC (Jacksonville), Jacksonville
- K2 Medical Research (Maitland), Maitland
- Clinical Neuroscience Solutions, LLC (Orlando), Orlando
- и још 1
Тражи се учесникФаза 3
Узраст од 18 до 74 · Оба пола · Ажурирано 9. 11. 2026. · NCT07592689Neuromodulation of Motivation and Reward Oscillations
- The BRAINS Lab at Florida State University, Tallahassee
- The Riddle Lab at Florida State University, Tallahassee
Тражи се учесникЗдраве особе су добродошле
Узраст од 18 до 55 · Оба пола · Ажурирано 9. 11. 2026. · NCT07924852Targeting Network Dysfunction in Apathy of Late-life Depression Using Digital Therapeutics
- AdventHealth Neuroscience Institute, Orlando
Тражи се учесник
Узраст 60 и старији · Оба пола · Ажурирано 6. 11. 2026. · NCT05877885ACP-211 Monotherapy for Major Depressive Disorder With Inadequate Antidepressant Response
- New Access Research and Medical Services, Inc., Fort Myers
- The Medici Medical Research, Hollywood
- Clinical Neuroscience Solutions, Inc., Orlando
- и још 2
Тражи се учесникФаза 2
Узраст од 18 до 65 · Оба пола · Ажурирано 5. 11. 2026. · NCT07284667A Study of Brenipatide in Adult Participants With Major Depressive Disorder
- Encore Medical Research, Hollywood
- K2 Medical Research - Maitland, Maitland
- Life Medical Research Group Corp, Miami Gardens
- и још 5
Тражи се учесникФаза 3
Узраст од 18 до 75 · Оба пола · Ажурирано 4. 11. 2026. · NCT07412756Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms
- Clinical Research of Brandon, Brandon
- Nuovida Research Center, Miami
- Psych Me Medical Research Inc, Tampa
- и још 2
Тражи се учесникФаза 3
Узраст од 18 до 74 · Оба пола · Ажурирано 3. 11. 2026. · NCT06559306A Study of Brenipatide (LY3537031) in Adult Participants With Major Depressive Disorder
- JEM Research Institute, Atlantis
- Bradenton Research Center, Inc., Bradenton
- Key Clinical Research, Bradenton
- и још 6
Тражи се учесникФаза 3
Узраст од 18 до 75 · Оба пола · Ажурирано 3. 11. 2026. · NCT07775300Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder
- Premier Clinical Research Institute, Miami
- Miami Jewish Health System, Miami
- Interventional Psychiatry of Tampa Bay, Tampa
Тражи се учесникФаза 3
Узраст од 18 до 65 · Оба пола · Ажурирано 3. 11. 2026. · NCT05850689A Study of Seltorexant as Monotherapy in Adults and Elderly Participants With Major Depressive Disorder
- UHC Research, Doral
- Reliable Clinical Research, Hialeah
- K2 Medical Research, Maitland
- и још 4
Тражи се учесникФаза 3
Узраст од 18 до 74 · Оба пола · Ажурирано 3. 11. 2026. · NCT07573176Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Neurocrine Clinical Site, Hollywood
- Neurocrine Clinical Site, Maitland
- Neurocrine Clinical Site, Maitland
- и још 6
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 2. 11. 2026. · NCT06966401A Study to Evaluate TNX-102 SL Monotherapy Versus Placebo in Participants With Major Depressive Disorder (MDD)
- Clinical Research Site, Jacksonville
- Clinical Research Site, Maitland
- Clinical Research Site, Miami
- и још 3
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 30. 10. 2026. · NCT07621237A Study to Evaluate the Safety and Efficacy of ALKS 7290 as an Adjunctive Therapy to Antidepressants in Adult Participants With Major Depressive Disorder
- Alkermes Investigator Site, Jacksonville
Тражи се учесникФаза 2
Узраст од 18 до 65 · Оба пола · Ажурирано 28. 10. 2026. · NCT07901179Double-blind, Placebo-controlled Study in Adults With Major Depressive Disorder
- CNS Healthcare - Jacksonville, Jacksonville
- Avantis Clinical Research, Miami
- CNS Healthcare of Orlando, Orlando
- и још 3
Тражи се учесникФаза 2
Узраст од 18 до 70 · Оба пола · Ажурирано 28. 10. 2026. · NCT07226661Study of ALTO-300 in MDD
- Site 221, Tampa
Тражи се учесникФаза 2
Узраст од 18 до 70 · Оба пола · Ажурирано 26. 10. 2026. · NCT05922878Neural Mechanisms of Real-world Emotions and Internalizing
- University of Miami, Coral Gables
Тражи се учесникЗдраве особе су добродошле
Узраст од 18 до 35 · Оба пола · Ажурирано 23. 10. 2026. · NCT07891624A Study to Evaluate the Maintenance Effect of Osavampator as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Neurocrine Clinical Site, Miami Gardens
- Neurocrine Clinical Site, Orlando
- Neurocrine Clinical Site, Palm Bay
- и још 1
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 22. 10. 2026. · NCT07196501Treatment ResistAnt Depression Subcallosal CingulatE Network DBS (TRANSCEND)
- USF Health, Tampa
Тражи се учесник
Узраст од 22 до 70 · Оба пола · Ажурирано 16. 10. 2026. · NCT06423430A Study to Evaluate the Effectiveness of DT-101 as an Adjunctive Treatment in Patients With Depression
- Draig Clinical Site, Hialeah
- Draig Clinical Site, Orlando
- Draig Clinical Site, Orlando
- и још 2
Тражи се учесникФаза 2
Узраст од 18 до 75 · Оба пола · Ажурирано 14. 10. 2026. · NCT07610473Clinical Assessment of Response in the Treatment of Depression With Daytime Sleepiness Using Solriamfetol
- Clinical Research Site, Jacksonville
- Clinical Research Site, Miami
- Clinical Research Site, Miami
Тражи се учесникФаза 3
Узраст од 18 до 65 · Оба пола · Ажурирано 13. 10. 2026. · NCT07484217A Study to Evaluate the Effectiveness of DT-101 in Patients With Depression
- Draig Clinical Site, Miami
- Draig Clinical Site, Orlando
Тражи се учесникФаза 2
Узраст од 18 до 75 · Оба пола · Ажурирано 8. 10. 2026. · NCT07300969Evaluation of Efficacy and Safety of Milsaperidone as Adjunctive Therapy in Patients With Major Depressive Disorder
- Vanda Investigational Site, Fort Myers
- Vanda Investigational Site, Miami
Тражи се учесникФаза 3
Узраст од 18 до 65 · Оба пола · Ажурирано 24. 9. 2026. · NCT06830044A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor
- Neurocrine Clinical Site, Bonita Springs
- Neurocrine Clinical Site, Hialeah
- Neurocrine Clinical Site, Miami
- и још 3
Тражи се учесникФаза 4
Узраст 18 и старији · Оба пола · Ажурирано 18. 9. 2026. · NCT07105111Causal Role of Delta-beta Coupling for Goal-directed Behavior in Anhedonic Depression
- Florida State University, Tallahassee
Тражи се учесник
Узраст од 18 до 65 · Оба пола · Ажурирано 31. 8. 2026. · NCT06132581NBI-1065845-MDD3025: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Neurocrine Clinical Site, Hollywood
- Neurocrine Clinical Site, Tampa
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 11. 8. 2026. · NCT06911112NBI-1065845-MDD3026: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Neurocrine Clinical Site, Maitland
- Neurocrine Clinical Site, Miami
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 10. 8. 2026. · NCT06963021Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder
- Clinical Neuroscience Solutions, Inc., Jacksonville
- D&H Pompano Research Center, LLC, Margate
- Premier Clinical Research Institute, Inc., Miami
- и још 2
Тражи се учесникФаза 2
Узраст од 18 до 64 · Оба пола · Ажурирано 3. 8. 2026. · NCT06547489A Phase 2 Study of Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder
- Clinical Neuroscience Solutions, Inc, Jacksonville
- Premier Clinical Research Institute Inc, Miami
- Aqualane Clinical Research, Naples
- и још 2
Тражи се учесникФаза 2
Узраст од 18 до 64 · Оба пола · Ажурирано 27. 7. 2026. · NCT07115329A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcaprant in Adult Participants With Major Depressive Disorder
- CenExel Hollywood FL /ID# 278200, Hollywood
- Cns Healthcare - Jacksonville /ID# 277658, Jacksonville
- GMI Florida - Central Miami Medical Institute /ID# 278218, Miami
- и још 2
Тражи се учесникФаза 2
Узраст од 18 до 65 · Оба пола · Ажурирано 15. 6. 2026. · NCT07276997Study of ABX-002 for the Adjunctive Treatment of Major Depressive Disorder (AMPLIFY)
- Autobahn Site #108, Brandon
- Autobahn Site #110, Hialeah
- Autobahn Site #101, Jacksonville
- и још 3
Тражи се учесникФаза 2
Узраст од 18 до 65 · Оба пола · Ажурирано 20. 1. 2026. · NCT06633016Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Neurocrine Clinical Site, Hollywood
- Neurocrine Clinical Site, Maitland
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 29. 10. 2025. · NCT06786624A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive Symptoms
- Clinical Research Site, Brandon
- Clinical Research Site, Doral
- Clinical Research Site, Hialeah
- и још 5
Тражи се учесникФаза 4
Узраст од 18 до 65 · Оба пола · Ажурирано 23. 1. 2025. · NCT06223880Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.